Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Vineela Parvathaneni
Mimansa Goyal
Nishant S. Kulkarni
Snehal K. Shukla
Vivek Gupta
机构：
[1] St. John’s University,Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences
来源：
Pharmaceutical Research | 2020年 / 37卷
关键词：
drug repositioning; nelfinavir; non-small cell lung cancer; 3D spheroid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [42] Evaluation of Toxicity Profile of ALK Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
    Hong, S.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2392 - S2392
  • [43] SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013
    C. Camps
    E. Felip
    R. García-Campelo
    J. M. Trigo
    P. Garrido
    Clinical and Translational Oncology, 2013, 15 : 977 - 984
  • [44] The Efficacy and Safety of Anti-PD-1 in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Systematic Review
    Di, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1917 - S1917
  • [45] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [46] Docetaxel (Taxotere®):: Current clinical development in non-small cell lung cancer (NSCLC)
    Manegold, C
    MEDIZINISCHE KLINIK, 1998, 93 (09) : A16 - A21
  • [47] SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013
    Camps, C.
    Felip, E.
    Garcia-Campelo, R.
    Trigo, J. M.
    Garrido, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (12) : 977 - 984
  • [48] The role of imaging in screening, diagnosis and staging of non-small cell lung cancer (NSCLC)
    Rankin, SC
    EJC SUPPLEMENTS, 2004, 2 (04): : 7 - 14
  • [49] Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)
    Liu, Si-Yang
    Wu, Yi-Long
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (12) : 1355 - 1363
  • [50] Platinum-based targeted chemotherapies and reversal of cisplatin resistance in non-small cell lung cancer (NSCLC)
    Umar, Hassaan
    Wahab, Habibah A.
    Attiq, Ali
    Amjad, Muhammad Wahab
    Bukhari, Syed Nasir Abbas
    Ahmad, Waqas
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2024, 828
12345